The shikimate pathway in apicomplexan parasites: implications for drug development.

Area of Science:

• Biochemistry
• Parasitology
• Drug Discovery

Background:

• The shikimate pathway synthesizes aromatic compounds crucial for life.
• This pathway is absent in humans but present in apicomplexan parasites.
• Its absence in humans makes it a promising target for antimicrobial therapies.

Purpose of the Study:

• To review the current knowledge of the shikimate pathway in apicomplexan parasites.
• To discuss the genetic organization of this pathway in parasites.
• To present potential drug compounds targeting shikimate pathway enzymes for anti-parasitic drug development.

Main Methods:

• Literature review of existing studies on the shikimate pathway in apicomplexan parasites.
• Analysis of genetic organization and enzyme functions.
• Compilation and discussion of compounds that inhibit shikimate pathway enzymes.

Main Results:

• The shikimate pathway is vital for apicomplexan parasites, producing essential aromatic compounds.
• Genetic organization of the pathway varies across parasite species.
• Several compounds show potential for inhibiting parasite growth by targeting this pathway.

Conclusions:

• The shikimate pathway represents a promising target for developing novel anti-apicomplexan and anti-plasmodial drugs.
• Further research into the pathway's genetic and enzymatic details is needed.
• Targeting this pathway offers a strategy to combat parasitic infections.